VA Office of Research and Development clinical trials
VA Office of Research and Development is the lead sponsor of 7 current clinical trials in our Mexico register. 5 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Carvedilol, Metformin and Metoprolol Succinate. The most-studied condition is Suicide, Attempted.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by VA Office of Research and Development
7 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
NCT05931276 · ClinicalTrials.gov ↗ · End-Stage Kidney Disease, End-Stage Renal Disease
Drugs: Carvedilol, Metoprolol Succinate |
Phase 3 | Recruiting | 2024-05 | Mexico |
|
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
NCT02915198 · ClinicalTrials.gov ↗ · Prediabetic State, Atherosclerosis, Metformin
Drug: Metformin |
Phase 4 | Recruiting | 2023-04 | Mexico |
|
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
NCT04373317 · ClinicalTrials.gov ↗ · Parkinson's Disease Psychosis
Drug: Quetiapine |
Phase 4 | Recruiting | 2022-10 | Mexico |
|
Enhancing Veteran-Clinical Collaboration in VA PRRCs
NCT06898879 · ClinicalTrials.gov ↗ · Schizophrenia, Schizoaffective Disorder, Delusional Disorder
|
Not applicable | Recruiting | 2026-08 | Mexico |
|
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
NCT05465044 · ClinicalTrials.gov ↗ · Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD), Dialysis Dependency
|
Not applicable | Recruiting | 2023-04 | Mexico |
|
DBT Skills Groups for Veterans at High Risk for Suicide Attempt
NCT05000749 · ClinicalTrials.gov ↗ · Suicide, Attempted
|
Not applicable | Active, closed | 2023-04 | Mexico |
|
Pentoxifylline in Diabetic Kidney Disease
NCT03625648 · ClinicalTrials.gov ↗ · Diabetic Kidney Disease
Drug: Pentoxifylline |
Phase 4 | Active, closed | 2019-11 | Mexico |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in VA Office of Research and Development trials
5 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in VA Office of Research and Development trials
15 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Mexico | 7 | 5 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Suicide, Attempted
| Sponsor | Trials |
|---|---|
| Ajou University School of Medicine | 1 |
Sponsors with the most current trials registered for this condition.
Questions about VA Office of Research and Development trials
How many clinical trials does VA Office of Research and Development sponsor?
VA Office of Research and Development is the lead sponsor of 7 current trials on ClinicalTrials.gov in our Mexico register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are VA Office of Research and Development trials recruiting?
Yes. 5 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is VA Office of Research and Development testing?
Its current trials name 5 drugs and biologicals as interventions. The most frequent are Carvedilol (1), Metformin (1), Metoprolol Succinate (1), Pentoxifylline (1) and Quetiapine (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.